ATE207481T1 - Kristallformen von 1-(5-methansulfonamidoindolyl- 2-carbonyl)-4-(3-(1-methylethylamino)-2- pyridinyl) piperazin - Google Patents

Kristallformen von 1-(5-methansulfonamidoindolyl- 2-carbonyl)-4-(3-(1-methylethylamino)-2- pyridinyl) piperazin

Info

Publication number
ATE207481T1
ATE207481T1 AT95911842T AT95911842T ATE207481T1 AT E207481 T1 ATE207481 T1 AT E207481T1 AT 95911842 T AT95911842 T AT 95911842T AT 95911842 T AT95911842 T AT 95911842T AT E207481 T1 ATE207481 T1 AT E207481T1
Authority
AT
Austria
Prior art keywords
methanesulfonamidoindolyl
methylethylamino
pyridinyl
carbonyl
piperazine
Prior art date
Application number
AT95911842T
Other languages
English (en)
Inventor
Jeffrey L Havens
Donald P Smith
Michael S Bergren
Mark A Lyster
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE207481T1 publication Critical patent/ATE207481T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
AT95911842T 1994-04-15 1995-03-01 Kristallformen von 1-(5-methansulfonamidoindolyl- 2-carbonyl)-4-(3-(1-methylethylamino)-2- pyridinyl) piperazin ATE207481T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22786094A 1994-04-15 1994-04-15
US31178094A 1994-09-23 1994-09-23
PCT/US1995/002166 WO1995028398A1 (en) 1994-04-15 1995-03-01 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine

Publications (1)

Publication Number Publication Date
ATE207481T1 true ATE207481T1 (de) 2001-11-15

Family

ID=26921831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95911842T ATE207481T1 (de) 1994-04-15 1995-03-01 Kristallformen von 1-(5-methansulfonamidoindolyl- 2-carbonyl)-4-(3-(1-methylethylamino)-2- pyridinyl) piperazin

Country Status (26)

Country Link
US (1) US6452007B1 (de)
EP (1) EP0755393B1 (de)
JP (1) JP3817261B2 (de)
KR (1) KR100364941B1 (de)
CN (1) CN1147253A (de)
AT (1) ATE207481T1 (de)
AU (1) AU693939B2 (de)
CA (1) CA2184598C (de)
CZ (1) CZ287164B6 (de)
DE (1) DE69523447T2 (de)
DK (1) DK0755393T3 (de)
ES (1) ES2164147T3 (de)
FI (1) FI111364B (de)
HU (1) HU226827B1 (de)
IL (1) IL113162A (de)
LV (1) LV12957B (de)
MX (1) MX9604831A (de)
MY (1) MY116830A (de)
NO (1) NO310024B1 (de)
NZ (1) NZ282211A (de)
PL (1) PL180776B1 (de)
PT (1) PT755393E (de)
RU (1) RU2136677C1 (de)
SK (1) SK282424B6 (de)
TW (1) TW393478B (de)
WO (1) WO1995028398A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004311B1 (ru) 1998-06-11 2004-02-26 Фармация Энд Апджон Компани Таблетированная фармацевтическая композиция непролонгированного действия
US6872811B1 (en) 1998-09-30 2005-03-29 Millennium Pharmaceuticals, Inc. HRPCa9 and HRPCa10 nucleic acids and polypeptides
GB0219660D0 (en) * 2002-08-23 2002-10-02 Astrazeneca Ab Therapeutic use
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565924A (en) 1968-07-01 1971-02-23 Wisconsin Alumni Res Found 25-hydroxycholfcalciferol
US3833622A (en) 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
GB1532682A (en) 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
WO1991009849A1 (en) * 1989-12-28 1991-07-11 The Upjohn Company Diaromatic substituted anti-aids compounds
US5599930A (en) * 1991-07-03 1997-02-04 The Upjohn Company Substituted indoles as anti-AIDS pharmaceuticals

Also Published As

Publication number Publication date
JP3817261B2 (ja) 2006-09-06
PL316688A1 (en) 1997-02-03
WO1995028398A1 (en) 1995-10-26
SK122996A3 (en) 1997-05-07
AU3513695A (en) 1995-11-10
PL180776B1 (pl) 2001-04-30
DE69523447T2 (de) 2002-05-16
IL113162A0 (en) 1995-06-29
KR970702275A (ko) 1997-05-13
CA2184598A1 (en) 1995-10-26
HU226827B1 (en) 2009-11-30
IL113162A (en) 1999-04-11
FI964114L (fi) 1996-10-14
MX9604831A (es) 1998-05-31
SK282424B6 (sk) 2002-01-07
RU2136677C1 (ru) 1999-09-10
EP0755393A1 (de) 1997-01-29
CZ287164B6 (en) 2000-10-11
US6452007B1 (en) 2002-09-17
HUT76467A (en) 1997-09-29
FI111364B (fi) 2003-07-15
HU9602857D0 (en) 1996-12-30
MY116830A (en) 2004-04-30
KR100364941B1 (ko) 2003-02-19
CZ294296A3 (en) 1997-01-15
FI964114A0 (fi) 1996-10-14
CA2184598C (en) 2005-05-03
AU693939B2 (en) 1998-07-09
NO964386D0 (no) 1996-10-15
DK0755393T3 (da) 2001-12-17
TW393478B (en) 2000-06-11
NZ282211A (en) 1997-10-24
ES2164147T3 (es) 2002-02-16
CN1147253A (zh) 1997-04-09
DE69523447D1 (de) 2001-11-29
EP0755393B1 (de) 2001-10-24
NO310024B1 (no) 2001-05-07
LV12957B (en) 2003-04-20
PT755393E (pt) 2002-04-29
NO964386L (no) 1996-10-15
JPH09512007A (ja) 1997-12-02

Similar Documents

Publication Publication Date Title
ATE236629T1 (de) Verwendung heterocyclischer verbindungen als dopamin-d 3 liganden
DE59610509D1 (de) Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz
NO970162L (no) Substituerte pyrimidinforbindelser og anvendelse derav
ATE172968T1 (de) Substituierte azadioxacycloalkene und ihre verwendung als fungizide
DE60023318D1 (de) Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren
BR9609888A (pt) Halogenobenzimidazóis
TR200201684T2 (tr) Fenilpiperazinil türevleri
BG101113A (bg) Триазолови съединения и тяхното използване
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ATE178886T1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
HUP9802447A2 (hu) Piperazinszármazékok, eljárás előállításukra és 5-HT1A antagonistaként történő alkalmazásuk
KR970702274A (ko) 콜레시스토키닌 또는 가스트린을 조절하는 5-헤테로시클릭-1, 5-벤조디아제핀(CCK or Gastrin Modulating 5-Heterocyclic-1,5-Benzodiazepines)
DE59410304D1 (de) N-substituierte azabicycloheptan-derivate und ihre verwendung, z.b., als neuroleptika
ATE207481T1 (de) Kristallformen von 1-(5-methansulfonamidoindolyl- 2-carbonyl)-4-(3-(1-methylethylamino)-2- pyridinyl) piperazin
ATE189894T1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
FR2707990B1 (fr) Nouvelles nitrones utilisables pour le piégeage des radicaux libres.
TW328951B (en) Substituted 2-phenylpyridines
TR199901291T2 (xx) Alzheimer hastal��� tedavisi i�in 1-fenilalkil-1,2,3,6-tetrahidro piridinler.
MX9703363A (es) Nuevos derivados de pirimidiniloxi- y pirimidinilamino etilfenil-dioxolano.
DE69912306D1 (de) 1,4-diaryl-2-fluor-1-buten-3-ol-verbindungen und ihre verwendung in der herstellung von 1,4-diaryl-2-fluor-1,3-butadien- und 1,4-diaryl-2-fluor-2-buten-verbindungen
DE59905342D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
YU26883A (en) Process for the manufacture of the crystalline alpha-form of 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-piperazine hydrochloride

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification